Overview
The goal of this pilot randomized controlled trial is to determine if a randomized controlled trial of a collaborative pharmacist-intensivist telehealth follow-up after intensive care unit discharge can feasibly be performed in patients who have survived a critical illness.
The study intervention will be telehealth follow-up appointments provided by clinical pharmacists at approximately one and three months post-hospital discharge. The purpose of the follow-up appointments will be to assess for post-intensive care syndrome and provide recommend interventions aimed at improving recovery
Participants will randomized to receive the study intervention or standard of care.
Eligibility
Inclusion Criteria:
- Adults 18-89 years of age
- Required admission to either medical or surgical ICU
- Respiratory failure requiring invasive mechanical ventilation of at least 24 hours during ICU stay; or ICU stay of at least 7 days
- Anticipated discharge to home after hospitalization
- Consent from patients themselves or a legally authorized representative if necessary
Exclusion Criteria:
- Pregnancy
- Incarceration/Imprisonment
- Life expectancy less than 6 months or enrolled in hospice/palliative care
- Anticipated discharge to skilled nursing facility, medical rehabilitation facility, or other long terms care facility
- Unable to participate in telehealth